Schumer, Gillibrand Announce $445,000 for Medical Reasearch, Treatment in the North Country
Federal Dollars Will Advance Research, Treatment to Fight Influenza
Washington, D.C. – U.S. Senators Charles E. Schumer and Kirsten Gillibrand today announced $445,000 in federal dollars from the U.S. Department of Health and Human Services (HHS) to advance research and treatment to fight influenza at Trudeau Institute, Inc. The federal investment for this North Country institute is part of the American Recovery and Reinvestment Act, which Senators Schumer and Gillibrand helped pass earlier this year.
“Federal funding for medical research and training is needed now more than ever,” said Schumer. “In these difficult economic times, it is critical that we continue to invest in cutting-edge medical research to push the boundaries of medicine and promote long-term economic growth. I will continue to fight for federal funds that will advance the Trudeau Institute, Inc as a world-class research institution.”
“It is critical that we invest in the life-saving research at our world class medical facilities in the North Country,” said Senator Gillibrand. “Federal funding for this cutting edge research and treatment will help improve lives while supporting economic growth in the North Country. I will continue to work with Senator Schumer to ensure that New York receives its fair share of federal dollars and improved healthcare initiatives.”
Trudeau Institute, Inc. in Saranac Lake will receive $445,000 in federal dollars to advance research and treatment of influenza by studying how memory T cells are generated to fight re-infection, which could lead to new vaccines against pathogens that continually mutate.
Senators Schumer and Gillibrand are strong supporters of President Obama’s economic plan. The investment will help create or save more than 200,000 jobs in New York, while laying the foundation of future economic growth with critical investments in health care technology and research, education, infrastructure and renewable energy.
Next Article Previous Article